About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

About Market Research Forecast

U.S. Platelet Rich Plasma Market

U.S. Platelet Rich Plasma Market Is Set To Reach USD Million By 2033, Growing At A CAGR Of 17.2

U.S. Platelet Rich Plasma Market by Product (Pure Platelet Rich Plasma {Pure PRP}, Leukocyte-rich Platelet Rich Plasma {L-PRP}, Platelet Rich Fibrin {PRF}, Others), by Application (Orthopedics, Neurology, Cosmetics, Wound Care, Others), by End User (Hospital & ASCs, Specialty Clinics, Others), by Forecast 2026-2034

Jun 17 2025

Base Year: 2025

150 Pages

U.S. Platelet Rich Plasma Market Is Set To Reach USD Million By 2033, Growing At A CAGR Of 17.2

Key Insights

The U.S. Platelet Rich Plasma Market size was valued at USD 117.2 USD Million in 2023 and is projected to reach USD 355.98 USD Million by 2032, exhibiting a CAGR of 17.2 % during the forecast period. PRP is a regenerative therapy that enriches the platelet in a patient's own blood to form a specific component which is used to treat such conditions and diseases that affect the forming of new cells and tissues. Classes can be divided into 2 types, the leukocyte-rich and leukocyte-poor, based on their levels of white blood cell counts. PRP factores high platelet concentration resulting in the release of growth factors responsible for tissue repair and regeneration. They can start with a simple orthopedics field, then, move on, to dermatology- and even cosmetics fields, like hair restoration. US, the thousand-dollar market allocates another $6.2 billion in medical expenses on basically minimally invasive treatments and advancing in medical technology as well. However, it also has its downsides in the form of regulations and reimbursement policies that restrict the market growth.

U.S. Platelet Rich Plasma Trends

Rising demand for non-surgical and minimally invasive treatments
Growing popularity of PRP therapy for cosmetic applications
Technological advancements in PRP preparation and delivery systems

U.S. Platelet Rich Plasma Market Market Size and Forecast (2024-2030) — U.S. Platelet Rich Plasma Market Company Market Share

Driving Forces: What's Propelling the U.S. Platelet Rich Plasma Market

Surging Prevalence of Chronic Diseases: The rising incidence of osteoarthritis, tendon injuries, and other musculoskeletal disorders fuels the demand for effective regenerative therapies like PRP, significantly impacting market growth.
Increased Awareness and Acceptance of PRP Therapy: Growing physician and patient understanding of PRP's efficacy and minimally invasive nature is driving adoption across various medical specialties. Improved patient education campaigns and positive clinical outcomes contribute to this trend.
Technological Advancements in PRP Processing and Delivery: Innovations in centrifugation technology, platelet concentration techniques, and delivery systems are enhancing treatment efficacy and expanding clinical applications, thereby stimulating market expansion.
Government Support and Funding for Regenerative Medicine: Increased research grants, regulatory approvals, and reimbursement policies are fostering innovation and accessibility of PRP therapies, creating a favorable environment for market growth. This includes initiatives promoting the adoption of advanced medical technologies.

Challenges and Restraints in U.S. Platelet Rich Plasma Market

High cost of PRP therapy: PRP therapy can be expensive, particularly for patients without insurance coverage.
Lack of standardized protocols: Different healthcare providers may use varying PRP preparation and administration techniques, leading to inconsistency in treatment outcomes.
Regulatory hurdles: The Food and Drug Administration (FDA) has yet to approve PRP for specific medical indications, which can create uncertainty among clinicians and patients.
Limited insurance coverage: Many insurance companies do not cover PRP therapy, making it financially burdensome for patients.
Potential risks: As with any medical procedure, PRP therapy carries potential risks such as infection, pain, and tissue damage if not performed correctly.
Need for further research: More clinical studies and research are necessary to establish the long-term efficacy and safety of PRP therapy for various medical conditions.

Emerging Trends in U.S. Platelet Rich Plasma

Development of new PRP preparation methods
Growing use of PRP in combination with other therapies
Advancements in PRP delivery systems

Growth Catalysts in the U.S. Platelet-Rich Plasma Industry

Increasing number of research studies supporting the benefits of PRP therapy
Entry of major players into the market
Rising demand for aesthetic procedures

Market Segmentation: U.S. Platelet Rich Plasma Analysis

Product:

Pure Platelet Rich Plasma (Pure PRP)
Leukocyte-rich Platelet Rich Plasma (L-PRP)
Platelet Rich Fibrin (PRF)

Application:

Orthopedics
Neurology
Cosmetics
Wound Care

End User:

Hospital & ASCs
Specialty Clinics

Leading Players in the U.S. Platelet Rich Plasma Market

Significant Developments in the U.S. Platelet-Rich Plasma Sector

June 2023: Isto Biologics launched Precise, a brand-new technology that delivers a final platelet-rich plasma product with precision cellular fractions upon concentration.
July 2021: Arthrex, Inc. entered into a strategic agreement with Celularity to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedic surgery and sports medicine in the U.S.
July 2021: Exactech, Inc. partnered with RTI Surgical to supply and develop biologic products, such as bone substitutes.

Comprehensive Coverage U.S. Platelet Rich Plasma Market Report

In-depth DROCT Analysis: A detailed examination of the market dynamics, including Drivers, Restraints, Opportunities, Challenges, and Threats, providing a holistic understanding of the market landscape.
Granular Pricing Analysis: Comprehensive analysis of price trends across various market segments and geographic locations, considering factors influencing price fluctuations and competitive dynamics.
Detailed Import and Export Analysis: A thorough examination of historical data, current market volume, and value, providing insights into international trade patterns and their impact on the U.S. market.
Robust Segmentation Analysis: A comprehensive breakdown of the market by product type, application (orthopedics, dermatology, dentistry, etc.), end-user (hospitals, clinics, ambulatory surgical centers), and geographic region, providing a nuanced view of market segments and growth potential.
Extensive Patent/Trademark Analysis: A detailed overview of recent patent filings, granted patents, and pending applications, offering insights into the competitive landscape and future innovation in the PRP market. This includes analysis of intellectual property rights and their potential impact on market competition.

U.S. Platelet Rich Plasma Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 17.2% from 2020-2034
Segmentation	By Product Pure Platelet Rich Plasma {Pure PRP} Leukocyte-rich Platelet Rich Plasma {L-PRP} Platelet Rich Fibrin {PRF} Others By Application Orthopedics Neurology Cosmetics Wound Care Others By End User Hospital & ASCs Specialty Clinics Others By Geography

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Rising Technological Developments in Products to Propel Market Growth
- - 3.3. Market Restrains
  - - 3.3.1. Stringent Regulatory Scenario and Relevant Side-Effects to Impede Growth Prospects
- - 3.4. Market Trends
  - - 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. U.S. Platelet Rich Plasma Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product
  - 5.1.1. Pure Platelet Rich Plasma {Pure PRP}
  - 5.1.2. Leukocyte-rich Platelet Rich Plasma {L-PRP}
  - 5.1.3. Platelet Rich Fibrin {PRF}
  - 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - by Application
  - 5.2.1. Orthopedics
  - 5.2.2. Neurology
  - 5.2.3. Cosmetics
  - 5.2.4. Wound Care
  - 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - by End User
  - 5.3.1. Hospital & ASCs
  - 5.3.2. Specialty Clinics
  - 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by Region
  - 5.4.1.
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Arthrex Inc. (U.S.)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Zimmer Biomet (U.S.)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Isto Biologics (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 ThermoGenesis Holdings Inc. (U.S.)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 Exactech Inc. (U.S.)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 EmCyte Corporation (U.S.)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Stryker (U.S.)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Medical Devices Business Services Inc. (Johnson & Johnson Services
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 Inc.) (U.S.)
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)
    - 6.2.10 Terumo Corporation (Japan)
      6.2.10.1. Overview
      6.2.10.2. Products
      6.2.10.3. SWOT Analysis
      6.2.10.4. Recent Developments
      6.2.10.5. Financials (Based on Availability)

List of Figures

Figure 1: U.S. Platelet Rich Plasma Market Revenue Breakdown (USD Million, %) by Product 2025 & 2033
Figure 2: U.S. Platelet Rich Plasma Market Share (%) by Company 2025

List of Tables

Table 1: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Product 2020 & 2033
Table 2: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Application 2020 & 2033
Table 3: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by End User 2020 & 2033
Table 4: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Region 2020 & 2033
Table 5: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Product 2020 & 2033
Table 6: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Application 2020 & 2033
Table 7: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by End User 2020 & 2033
Table 8: U.S. Platelet Rich Plasma Market Revenue USD Million Forecast, by Country 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Platelet Rich Plasma Market?

The projected CAGR is approximately 17.2%.

2. Which companies are prominent players in the U.S. Platelet Rich Plasma Market?

Key companies in the market include Arthrex, Inc. (U.S.), Zimmer Biomet (U.S.), Isto Biologics (U.S.), ThermoGenesis Holdings, Inc. (U.S.), Exactech, Inc. (U.S.), EmCyte Corporation (U.S.), Stryker (U.S.), Medical Devices Business Services, Inc. (Johnson & Johnson Services, Inc.) (U.S.), Terumo Corporation (Japan).

3. What are the main segments of the U.S. Platelet Rich Plasma Market?

The market segments include Product, Application, End User.

4. Can you provide details about the market size?

The market size is estimated to be USD 117.2 USD Million as of 2022.

5. What are some drivers contributing to market growth?

Rising Technological Developments in Products to Propel Market Growth.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

Stringent Regulatory Scenario and Relevant Side-Effects to Impede Growth Prospects.

8. Can you provide examples of recent developments in the market?

June 2023- Isto Biologics launched Precise, a brand-new technology that delivers a final platelet rich plasma product with precision cellular fractions upon concentration. This product allows physicians and surgeons to customize their PRP to fit patient needs.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD Million.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "U.S. Platelet Rich Plasma Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the U.S. Platelet Rich Plasma Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the U.S. Platelet Rich Plasma Market?

To stay informed about further developments, trends, and reports in the U.S. Platelet Rich Plasma Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

Platelet Rich Plasma Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Human Platelet Lysate Market Strategic Insights: Analysis 2025 and Forecasts 2033

Platelet Rich Plasma 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Platelet Rich Plasma (PRP) Soars to 769 million , witnessing a CAGR of 10.9 during the forecast period 2025-2033

Platelet-Rich Plasma Injection 5 CAGR Growth Outlook 2025-2033

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report